These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 14629831
1. Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4. Li Y, Jin Y, Chen H, Jie G, Tobelem G, Caen JP, Han ZC. Cancer Biother Radiopharm; 2003 Oct; 18(5):829-40. PubMed ID: 14629831 [Abstract] [Full Text] [Related]
2. [Transfer of cDNAs of platelet factor 4 and N-truncated peptide inhibits solid tumor growth in vivo]. Li Y, Liu Y, Jin Y, Zhou Y, Cai Y, Chen H, Zhang L, Han Z. Zhonghua Yi Xue Za Zhi; 2002 Jan 10; 82(1):35-8. PubMed ID: 11953124 [Abstract] [Full Text] [Related]
3. [Inhibition of tumor angiogenesis in nude mice by adenovirus-mediated PF4 p17-70 cDNA transfection]. Wu LH, Song GL, Diao SY, Cai YL, Li YH, Li SZ, Yang RC, Han ZC. Zhonghua Xue Ye Xue Za Zhi; 2003 Aug 10; 24(8):426-9. PubMed ID: 14642182 [Abstract] [Full Text] [Related]
4. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Tanaka T, Manome Y, Wen P, Kufe DW, Fine HA. Nat Med; 1997 Apr 10; 3(4):437-42. PubMed ID: 9095178 [Abstract] [Full Text] [Related]
6. [Suppression of multiple myeloma tumor growth in vivo by transfection of platelet factor 4 or 17-70 cDNA]. Yang LJ, Jiang H, Zou JF, Hou J. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct 10; 18(5):1172-6. PubMed ID: 21129255 [Abstract] [Full Text] [Related]
8. Viral vector-mediated transduction of a modified thrombospondin-2 cDNA inhibits tumor growth and angiogenesis. Hahn W, Ho SH, Jeong JG, Hahn EY, Kim S, Yu SS, Kim S, Kim JM. Gene Ther; 2004 May 10; 11(9):739-45. PubMed ID: 15103317 [Abstract] [Full Text] [Related]
9. Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivo. Yang L, Du J, Hou J, Jiang H, Zou J. BMC Cancer; 2011 Jun 21; 11():261. PubMed ID: 21693026 [Abstract] [Full Text] [Related]
10. A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo. Ciafrè SA, Barillari G, Bongiorno-Borbone L, Wannenes F, Izquierdo M, Farace MG. Gene Ther; 2002 Feb 21; 9(4):297-302. PubMed ID: 11896469 [Abstract] [Full Text] [Related]
11. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer. Lee YK, So IS, Lee SC, Lee JH, Lee CW, Kim WM, Park MK, Lee ST, Park DY, Shin DY, Park CU, Kim YS. J Gene Med; 2005 Feb 21; 7(2):145-57. PubMed ID: 15546163 [Abstract] [Full Text] [Related]
12. Gene therapy-mediated expression by tumor cells of the angiogenesis inhibitor flk-1 results in inhibition of neuroblastoma growth in vivo. Davidoff AM, Leary MA, Ng CY, Vanin EF. J Pediatr Surg; 2001 Jan 21; 36(1):30-6. PubMed ID: 11150434 [Abstract] [Full Text] [Related]
13. Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy. Liu TC, Zhang T, Fukuhara H, Kuroda T, Todo T, Martuza RL, Rabkin SD, Kurtz A. Mol Ther; 2006 Dec 21; 14(6):789-97. PubMed ID: 17045531 [Abstract] [Full Text] [Related]
14. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma. Zhao X, Zhu DM, Gan WJ, Li Z, Zhang JL, Zhao H, Zhou J, Li DC. Oncol Rep; 2013 Mar 21; 29(3):1019-26. PubMed ID: 23254994 [Abstract] [Full Text] [Related]
15. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo. Riccioni T, Cirielli C, Wang X, Passaniti A, Capogrossi MC. Gene Ther; 1998 Jun 21; 5(6):747-54. PubMed ID: 9747454 [Abstract] [Full Text] [Related]
16. An induced pluripotent stem cell-mediated and integration-free factor VIII expression system. Yakura Y, Ishihara C, Kurosaki H, Kazuki Y, Komatsu N, Okada Y, Doi T, Takeya H, Oshimura M. Biochem Biophys Res Commun; 2013 Feb 08; 431(2):336-41. PubMed ID: 23291180 [Abstract] [Full Text] [Related]
17. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination. Yu HK, Ahn JH, Lee HJ, Lee SK, Hong SW, Yoon Y, Kim JS. J Gene Med; 2005 Jan 08; 7(1):39-49. PubMed ID: 15517541 [Abstract] [Full Text] [Related]
18. Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection. Li KQ, Li WL, Peng SY, Shi XY, Tang HL, Liu YB. Chin Med J (Engl); 2004 Sep 08; 117(9):1364-9. PubMed ID: 15377430 [Abstract] [Full Text] [Related]
19. Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model. Li YY, Qian GS, Huang GJ, Chen F, Qian P, Yu SC, Wang CZ, Li Q, Wang JC, Wu GM. Cancer J; 2006 Sep 08; 12(2):136-46. PubMed ID: 16630405 [Abstract] [Full Text] [Related]
20. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Maione TE, Gray GS, Hunt AJ, Sharpe RJ. Cancer Res; 1991 Apr 15; 51(8):2077-83. PubMed ID: 1706960 [Abstract] [Full Text] [Related] Page: [Next] [New Search]